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ABSTRACT
Background: Challenge testing with wheat plus exercise andor aspirin is a gold standard for the diagnosis of
wheat-dependent exercise-induced anaphylaxis (WDEIA); however, the test may often yield false-negative re-
sults. Our previous study suggested that an increase in serum wheat gliadin levels is required to induce allergic
symptoms in patients with WDEIA. Based on this knowledge, we sought to extract the patients with false nega-
tive results in the challenge tests of WDEIA.
Methods: Thirty-six patients with suspected WDEIA were enrolled. First, group categorizations―Group I,
challenge tests were positive; Group II, challenge tests were negative and serum gliadin were undetectable;
Group III, challenge tests were negative and serum gliadin were detectable―were given according to the re-
sults of wheat plus exercise andor aspirin challenge testing and serum gliadin levels. Second, diagnoses were
made using retests andor dietary management in Group II and III.
Results: Positive results for wheat plus exercise andor aspirin challenge tests gave a diagnosis of definite
WDEIA in 17 of 36 patients (Group I). Of the remaining 19 challenge negative patients, serum gliadin was un-
detectable in ten patients (Group II). Of the ten patients (Group II), three of them were diagnosed as definite
WDEIA by retesting and six of them were diagnosed as probable WDEIA using a wheat elimination diet,
whereas one patient was non-WDEIA. In the rest of the nine challenge negative patients, serum gliadin was de-
tectable (Group III). No allergic episodes with a normal diet provided a diagnosis of non-WDEIA in seven of the
nine patients, whereas the remaining two patients were probable WDEIA or had another food allergy because
of repeated episodes.
Conclusions: Our study revealed that serum gliadin monitoring during challenge testing is useful.
KEY WORDS
challenge test, serum gliadin monitoring, wheat-dependent exercise-induced anaphylaxis, ω-5 gliadin
Allergology International. 2013;62:229-238
ORIGINAL ARTICLE
1Department of Dermatology, Faculty of Medicine, Shimane Uni-
versity, Shimane, 2Department of Pathophysiology and Therapeu-
tics, 5Department of Dermatology, Programs for Biomedical Re-
search, Division of Molecular Medical Science, Graduate School of
Biomedical Sciences, Hiroshima University, Hiroshima, 3Morinaga
Institute of Biological Science Inc., Kanagawa and 4Department of
Dermatology, Nishi-Kobe Medical Center, Hyogo, Japan.
Authors’ contributions: KK, HM and EM conceived the experi-
ments. KK performed the experiments, and analyzed the data to-
gether with HT, HM. Recruitment of patients and the challenge
testing were performed by EM, HN, SK, YC, TH, SM and EM. TH
prepared the serum gliadin detection kit. KK, HM and EM co-wrote
the paper. All authors discussed the results and commented on
the manuscript.
Conflict of interest: TH is employed by Morinaga Institute of Bio-
logical Science Inc.. The rest of the authors have no conflict of in-
terest.
Correspondence: Kunie Kohno, Department of Dermatology, Fac-
ulty of Medicine, Shimane University, 89−1 Enya-cho, Izumo, Shi-
mane 693−8501, Japan.
Email: nine_kk@med.shimane−u.ac.jp
Received 22 August 2012. Accepted for publication 20 December
2012.
2013 Japanese Society of Allergology
DOI: 10.2332allergolint.12-OA-0495
Kohno K et al.
230 Allergology International Vol 62, No2, 2013 www.jsaweb.jp
ABBREVIATIONS
FDEIA, food-dependent exercise-induced anaphylaxis; HMW-glutenin, high-molecular-weight glutenin subunit;
NSAIDs, non-steroidal anti-inflammatory drugs; WDEIA, wheat-dependent exercise-induced anaphylaxis.
INTRODUCTION
Food-dependent exercise-induced anaphylaxis (FDEIA)
is a severe form of food allergy, in which symptoms
are elicited by exercise in combination with ingestion
of the culprit food.1-3 Other factors that elicit allergic
symptoms in addition to exercise include non-
steroidal anti-inflammatory drugs (NSAIDs), alcohol,
patient’s general conditions and atmospheric condi-
tions.3-5 In Japanese patients, the most frequent cause
of FDEIA is wheat, which is found in almost 60% of
culprit foods.3,6 In contrast, vegetables are the most
frequent culprit food in European cases of FDEIA.7
Diagnosis of FDEIA is made based on detailed in-
terviews, allergy skin testing, detection of serum
allergen-specific IgE, and challenge testing. In the
case of wheat-dependent exercise-induced anaphy-
laxis (WDEIA), skin testing with commercial wheat
extract is not always reliable because the wheat ex-
tract consists largely of water-soluble proteins and
only a trace amount of water-insoluble proteins (glu-
ten) that are the major cause of WDEIA.8 A specific
IgE test with recombinant ω-5 gliadin is highly reli-
able and now widely used to identify the patients with
WDEIA. However, the test did not positively identify
approximately 20% of cases.9-13 The exercise chal-
lenge test combined with wheat ingestion is the most
definitive test to diagnose WDEIA, if the test elicits al-
lergic symptoms. However, WDEIA, cannot be ex-
cluded when the challenge test is negative, because
the challenge tests are not always successful. The
success of a test is highly dependent on the amount
of wheat, intensity of exercise and the condition of
the patients.3,14 Therefore, a negative test may turn
out to be a false-negative result.
In a previous study, we found that gliadin concen-
trations markedly increased in the sera of patients
with WDEIA in parallel with allergic symptoms dur-
ing positive challenge testing.15 We also demon-
strated that aspirin, a well-documented trigger of
WDEIA even in patients without a history of exacer-
bation due to NSAIDs,5,6 had an ability to increase
the serum concentration of gliadin when taken before
wheat ingestion.16 These observations indicated that
both exercise and aspirin intake cause an absorption
of non-digested gliadin from the intestine into the
blood circulation. In addition, we found that the in-
crease in serum gliadin also occurred in healthy sub-
jects.15,16 Taken together, we consider that the
amount of allergen-absorbed via the intestine is criti-
cal for eliciting the allergic symptoms of WDEIA seen
after wheat ingestion.
Herein, we propose a new index to determine
whether there was a sufficient challenge to cause gli-
adin absorption, by combining wheat plus exercise
andor aspirin challenge testing with serum gliadin
monitoring.
METHODS
SUBJECTS
Thirty-six patients (17 female and 19 male; mean age,
34.9 years; range, 9-71 years), who experienced aller-
gic symptoms after ingesting wheat-containing foods
in combination with exercise andor NSAIDs were
enrolled in this study. Table 1 lists the patient charac-
teristics, clinical histories, total IgE and specific IgE
levels for wheat, gluten, ω-5 gliadin and high-
molecular-weight glutenin subunit (HMW-glutenin).
Twenty-nine of the 36 patients experienced more
than three allergic episodes (patients 1-18, 20-25, 27-
29, 33 and 35), two patients had two episodes (patient
26 and 34) and five had one episode (patients 19, 30-
32, and 36). Clinical histories included urticaria, gen-
eralized erythema, palpebral edema, sneezing, laryn-
geal edema, dyspnea, nausea and anaphylaxis. All pa-
tients provided informed consent prior to participa-
tion in the study. Approval for the study was obtained
from the Ethics Committee of the Faculty of Medi-
cine at Shimane University (No. 121).
MEASUREMENT OF SERUM ALLERGEN-SPE-
CIFIC IgE
IgE antibodies specific for wheat, gluten, ω-5 gliadin
and HMW-glutenin were detected using the CAP-
fluorescent-enzyme immunoassay (ImmunoCAP,
Phadia, Uppsala, Sweden) as previously de-
scribed.10,11 Values >0.35 kUAL were judged to be
positive in this study.
CHALLENGE TESTS
Challenge tests for WDEIA were performed as previ-
ously described.15 The tests involved wheat inges-
tion, exercise, pretreatment with aspirin or a combi-
nation of these challenges on a separated day (Fig.
1). Briefly, the wheat products included noodles,
bread or pasta containing 60-135 g of wheat flour.
Thirty minutes after wheat ingestion, exercise was
performed using a treadmill for 15-20 min according
to the standard Bruce protocol. Aspirin (500 mg) was
administrated 30 min prior to wheat ingestion. A posi-
tive test was determined if allergic symptoms such as
wheals andor anaphylaxis were observed. During
the challenge tests, 9 mL of blood was drawn at each
time point via an indwelling needle. Patients with
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Table　1　Patient characteristics and clinical and laboratory data
Group Patient No.
Age 
(years)
Gen-
der
Epi-
sodes Symptoms during episodes
Total IgE
(kIU/L)
Specifi c IgE (kUA/L)
Wheat Gluten ω-5 gliadin
HMW-
glutenin
Group I 
(n = 17)
1 32 M >3 Anaphylaxis, Urticaria 146 <0.35 <0.35 5.35 <0.35
2 61 M >3 Anaphylaxis, Systemic urticaria 45 1.76 1.55 9.08 <0.35
3 36 F >3 Anaphylaxis, Urticaria 201 0.42 0.65 12.3 <0.35
4 16 M >3 Anaphylaxis, Systemic urticaria 80 <0.35 <0.35 3.72 <0.35
5 44 M >3 Anaphylaxis, Systemic urticaria 150 <0.35 <0.35 5.45 <0.35
6 52 F >3 Anaphylaxis, Urticaria, Dyspnea 260 0.37 0.66 5.15 <0.35
7 15 M >3 Dyspnea, Urticaria 590 <0.35 2.10 <0.35 <0.35
8 17 M >3 Anaphylaxis, Urticaria 602 1.34 0.52 13.1 <0.35
9 43 F >3 Anaphylaxis, Systemic urticaria 105 <0.35 <0.35 2.14 <0.35
10 25 F >3 Anaphylaxis, Systemic urticaria 1007 1.32 2.84 16.3 <0.35
11 19 M >3 Anaphylaxis, Wheezing, urticaria 109 <0.35 <0.35 <0.35 3.53
12 38 F >3 Anaphylaxis, Systemic urticaria 660 0.66 1.52 4.22 <0.35
13 23 M >3 Dyspnea, Generalized erythema 212 15.3 17.3 <0.35 <0.35
14 47 F >3 Anaphylaxis, Urticaria 107 <0.35 <0.35 2.15 -
15 57 F >3 Anaphylaxis, Systemic urticaria 292 <0.35 0.51 5.96 <0.35
16 58 M >3 Anaphylaxis, Systematic urticaria 22 <0.35 0.51 2.20 <0.35
17 17 M >3 Anaphylaxis, Systematic urticaria 2220 13.1 <0.35 <0.35 <0.35
Group II 
(n = 10)
18 34 F >3 Anaphylaxis, Generalized erythema 770 0.76 0.90 14.1 <0.35
19 65 F 1 Systemic urticaria, Dyspnea 1190 0.78 0.90 15.5 <0.35
20 12 M >3 Anaphylaxis, Systemic urticaria 126 1.21 <0.35 <0.35 1.36
21 34 M >3 Anaphylaxis, Systemic urticaria 5420 4.26 13.5 74.9 <0.35
22 14 M >3 Palpebral edema, Systemic urticaria 36 <0.35 <0.35 <0.35 0.42
23 48 M >3 Anaphylaxis, Urticaria 2028 <0.35 <0.35 1.63 <0.35
24 9 M >3 Anaphylaxis, Systemic urticaria 343 <0.35 <0.35 <0.35 1.72
25 18 F >3 Systemic urticaria 20022 11.7 1.06 0.49 0.39
26 24 F 2 Urticaria 434 <0.35 0.83 5.72 <0.35
27 24 F >3 Impetiginous eczema 10001 0.95 <0.35 <0.35 <0.35
Group III 
(n = 9)
28 40 F >3 Anaphylaxis, Urticaria, Nausea 111 <0.35 <0.35 2.44 <0.35
29 28 F >3 Palpebral and laryngeal edema, Sneeze, 
Dyspnea
360 0.94 0.44 <0.35 <0.35
30 28 F 1 Systemic urticaria 278 1.19 1.23 <0.35 <0.35
31 18 M 1 Dyspnea, Palpebral edema 749 0.50 <0.35 <0.35 <0.35
32 71 F 1 Anaphylaxis, Systemic urticaria 412 2.17 0.55 <0.35 <0.35
33 64 M >3 Anaphylaxis 541 <0.35 <0.35 0.36 <0.35
34 18 M 2 Anaphylaxis, Systemic urticaria 1699 <0.35 <0.35 <0.35 <0.35
35 60 M >3 Anaphylaxis, Systemic urticaria 186 <0.35 <0.35 <0.35 <0.35
36 48 F 1 Anaphylaxis, Systemic urticaria 160 <0.35 <0.35 <0.35 <0.35
Gender: M; male, F; female.
Anaphylaxis: a condition showing symptoms caused by insufficient blood circulation.
-, not done.
negative challenge test results were divided into
either an undetectable (<15 pgml) (Group II) or a
detectable (15 pgm) (Group III) according to their
serum gliadin concentration.
SERUM GLIADIN MONITORING
Serum gliadin concentrations were determined using
an ELISA kit for wheat gliadin (Morinaga Institute of
Biological Science, Yokohama, Japan) as previously
described.15 Briefly, 0.25 ml of serum was mixed with
0.05 ml deionized water and 0.7 ml ethanol and the
mixture was vortexed for 1 min. The mixture was
then centrifuged at 20,000 g for 20 min at room tem-
perature. The gliadin-containing supernatant was de-
canted into a new tube, and evaporated in a vacuum
centrifuge evaporator (VEC-260, Iwaki Glass Co.,
Kohno K et al.
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Fig.　1　Challenge test conditions and time-course of blood sampling. Test conditions are shown 
in the left-hand column and time points for blood collection in the right-hand column. PC, pre-chal-
lenge; W in a black square indicates wheat ingestion; E in a gray square indicates exercise; A in a 
white pentagon indicates aspirin ingestion; the black inverted triangle indicates point of blood 
sampling.
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Ltd., Chiba, Japan). The dried residue was dissolved
in 0.05 ml of the sample dilution buffer included in
the kit and the gliadin concentration measured ac-
cording to the manufacturer’s instructions. The gli-
adin concentration in each sample was calculated us-
ing a gliadin standard (Tokyo Kasei Kogyo Co., Ltd.,
Tokyo, Japan). All measurements were performed in
duplicate. The detection limit of serum gliadin level
was 15 pgmL.
DIAGNOSTIC PROCEDURE
The patients were divided into three groups after
challenge testing combined with serum gliadin moni-
toring as illustrated in Figure 2. Patients who were
evaluated as having a positive result in the challenge
tests were included in the group of definite WDEIA
(Group I). Patients with negative challenge test re-
sults were divided into either an undetectable (Group
II) or a detectable (Group III) according to their se-
rum gliadin concentration. The Group II patients
were considered insufficiently challenged and were
required to undergo retesting. Patient with positive
retests were considered as definite WDEIA. Patients
with a negative retest, with undetectable serum gli-
adin, were considered as a failure of retesting and fol-
lowed with a diet management. Those who declined
retests also followed with a diet management. The di-
agnostic endpoint of the diet management was the
clinical outcomes during a 1-year follow-up of wheat
elimination diet or exercise-restriction after their
meals. If the patient did not experience symptoms
during the 1-year follow-up, a diagnosis of probable
WDEIA was given. If a patient in this group had re-
current symptoms without wheat plus exercise and
or NSAIDs, a diagnosis of non-WDEIA was given.
The Group III patients maintained a normal diet for a
year, and during this time their allergic symptoms
were carefully monitored. If a patient in this group
had no symptoms during the year, a diagnosis of non-
WDEIA was given. If a patient in this group had re-
current symptoms with wheat plus exercise andor
NSAIDs, a diagnosis of probable WDEIA or other
food allergy was considered.
RESULTS
CHALLENGE TESTS AND SERUM GLIADIN
MONITORING
All patients participated in the challenge testing and
serum gliadin was monitored throughout the chal-
lenge test. The results of the challenge testing and
the maximal serum gliadin concentrations are sum-
marized in Table 2. All 36 patients had a negative re-
action to a single challenge with wheat, exercise or
aspirin. Of the 36 patients, 17 had a positive reaction
with either wheat plus exercise, aspirin plus wheat or
aspirin plus wheat plus exercise. However, 19 pa-
tients had a negative reaction even in the combina-
tion challenge of wheat and exercised andor aspirin.
Representative patterns of serum gliadin kinetics
are shown in Figure 3. Figure 3A shows the kinetics
of patient 1 who had a positive challenge test with
wheat and exercise. A similar pattern was seen for an-
other seven patients (patients 2-7 and 16). Figure 3B
shows the kinetics of patient 11, who had a positive
Serum Gliadin Monitoring in WDEIA
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Fig.　2　Diagnostic procedure for WDEIA. Black-framed rectangles indicate criteria for the group 
categorization; black-framed gray rectangles indicate the follow-up for the diagnosis; rounded gray 
squares indicate the diagnosis.
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Normal diet
Definite or probable WDEIA Non-WDEIA Other food allergy?
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serum gliadin monitoring
challenge test with aspirin and wheat. A similar pat-
tern was seen for another seven patients (patients 6-
10, 12 and 16). Figure 3C shows the kinetics of pa-
tient 13, who developed allergic symptoms after a tri-
ple challenge. This pattern was also observed for pa-
tient 14-17. Neither symptoms nor an increase in se-
rum gliadin concentrations were seen under any of
the test conditions in ten patients (patients 18-27, Fig.
3D). Serum gliadin was detected in patient 31 even af-
ter a negative challenge test with aspirin and wheat
(Fig. 3E). A similar pattern was observed for patients
28 and 30-35. In patients 29 and 36, serum gliadin was
detected without allergic symptoms after a triple chal-
lenge. In the 17 patients with negative challenge test-
ing (patient 18-34), serum gliadin was undetectable in
10 patients (patient 18-27) but was detectable in
seven patients (patient 28-36).
CATEGORIZATION OF PATIENTS BY DIAGNOS-
TIC PROCEDURE
According to the diagnostic procedure, patients were
categorized into three groups (Fig. 2). A diagnosis of
definite WDEIA was made in 17 patients and they
were categorized into Group I (patients 1-17). Those
who were negative to wheat plus exercise andor as-
pirin challenge with undetectable serum gliadin were
categorized into Group II (patients 18-27). Those who
had negative challenge testing with detectable serum
gliadin concentration were categorized into Group III
(patients 28-36).
ELIMINATION DIET TREATMENT AND FINAL DI-
AGNOSES IN THE GROUP II
Patients in Group II were proceeded to either retest
andor follow a wheat elimination diet. Table 3 sum-
marizes the results. Three patients (patient 18-20)
were found to be positive by retesting, whereas pa-
tient 21 had negative test. Patient 21 then followed a
further elimination diet and experienced recurrence
of urticaria with accidental ingestion of wheat product
and exercise. Patient 22 visited the emergency room
with anaphylactic shock after accidental ingestion of
curry, and had a serum gliadin level of 137 pgmL.
The other four patients (patient 23-26) had no allergic
symptoms after following a wheat-free diet for more
than 1 year, resulting in a diagnosis of probable
WDEIA. Patient 27 experienced recurrent symptoms
despite wheat elimination and was diagnosed as non-
WDEIA. In this procedure, definite WDEIA was diag-
nosed in three patients, probable WDEIA was diag-
nosed in six patients, and non-WDEIA was diagnosed
in one patient.
NORMAL DIET TREATMENT AND FINAL DIAG-
NOSIS IN THE GROUP III
A final diagnosis of non-WDEIA was given for 79 pa-
tients (patients 30-36) in Group III who experienced
no symptoms after a normal diet for more than 1
year. Patient 28, who experienced repetitive episodes
after a combination of wheat and exercise, was given
a final diagnosis of probable WDEIA. In patient 28,
challenge testing and serum gliadin monitoring ex-
cluded WDEIA. Because she has ω-5 gliadin specific
IgE (2.44 kUAL), which is higher than the cutoff
Kohno K et al.
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Table　2　Challenge test and serum gliadin results during testing
Group Patient No.
Wheat Exercise Wheat + Exercise Aspirin
Aspirin + 
Wheat
Aspirin + 
Wheat + 
Exercise
Retest
(based on the 
episode)
Result Glia-din Result
Glia-
din Result
Glia-
din Result
Glia-
din Result
Glia-
din Result
Glia-
din Result
Glia-
din
Group I 
(n = 17)
 1 N ud N ud P 127 - - - - - - - -
 2 N ud N ud P 216 - - - - - - - -
 3 N ud N ud P  15 N - N - - - - -
 4 N - N - P  27 - - - - - - - -
 5 N - N - P  65 N - N - P - - -
 6 N ud N ud P  17 N - P  43 - - - -
 7 N 16 N ud P  96 N - P  15 - - - -
 8 N ud N ud N  18 N ud P  18 - - - -
 9 N 30 - - - - N - P 132 - - - -
10 N 25 - - - - N ud P  76 - - - -
11 N 18 - - - - N ud P 107 - - - -
12 N ud - - - - - - P 200 - - - -
13 N ud N ud N ud N ud N ud P  18 - -
14 N ud - - N ud N - N ud P  19 - -
15 N - - - N ud - - - - P  91 - -
16 N - N ud P  53 N - P  52 P 122 - -
17 N - N - N - - - - - P 333 - -
Group II 
(n = 10)
18 N ud - - - - - - N ud - - P 18
19 N ud - - N ud N - N - N ud P ud
20 N ud - - N ud - - - - N ud P 62
21 N ud - - - - - - N ud - - N ud
22 N ud - - - - N ud N ud - - - -
23 N ud - - N ud - - N ud - - - -
24 N ud N ud N ud - - - - - - - -
25 N ud - - - - - - N ud - - - -
26 N ud N ud N ud - - - - - - - -
27 N - - - - - - - N ud - - - -
Group III 
(n = 9)
28 N ud N ud N ud - - N  20 - - - -
29 N ud N ud N ud - - - - N  29 - -
30 N ud - - N ud - - N 133 - - - -
31 N ud - - - - N ud N  61 - - - -
32 N 35 - - - - - - N  70 - - - -
33 N ud - - - - N - N  31 - - - -
34 N - - - - - N - N 181 - - - -
35 N - - - - - - - N 234 - - - -
36 N - - - - - - - - - N 255 - -
Gliadin, serum gliadin concentration (pg/mL); P, positive; N, negative; ud, under the detection limit; -, not done.
Patient 18 showed urticaria when exercising after ingesting a sweet bun. Patient 19 showed urticaria after a combination of bread, aspirin, 
rebamipide, itopride, and exercise (in accordance with her medical history), although neither rebamipide nor itopride induced symptoms in-
dividually. Patient 20 showed urticaria after ingesting bread and exercise. Patient 21 was retested with additional condition; sweet bun with 
cream was ingested instead of noodles, neither serum gliadin nor symptom were induced.
value we have previously reported, she was consid-
ered as probable WDEIA. Although patient 29 must
be retested within additional conditions, we could not
get the patients cooperation to do so. Patient 29 did
not have specific IgEs to ω-5 gliadin nor HMW-
glutenin. Thus there is still the possibility that patient
has another food allergy.
DISCUSSION
In the present study, we provided evidence that se-
Serum Gliadin Monitoring in WDEIA
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Fig.　3　Time course of serum gliadin kinetics. A, B, C, D and E show patterns in patients 1, 11, 13, 
21 and 31, respectively. Circle, cross, diamond, x, triangle and square indicate challenge with wheat, 
exercise, wheat + exercise, aspirin, aspirin + wheat and aspirin + wheat + exercise, respectively. The 
dotted line indicates the detection limit (<15 pg/mL). PC, pre-challenge; conc., concentration.
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D
rum gliadin monitoring is a good tool to use in check-
ing the efficacy of challenge tests for the diagnosis of
WDEIA, since a lack of increased serum gliadin can
prove an insufficient challenge test. We focused on an
extraction of WDEIA-suspected patients who had
negative results of the challenge test, because it was
believed that an elevation of serum gliadin is required
to develop allergic symptoms in WDEIA. As with our
previous study, increased serum gliadin levels were
observed in the patients with positive challenge test-
ing, supporting research that gliadin levels in the sera
correlate with allergic symptoms in WDEIA.15 The
patients who had shown negative challenge testing
were divided into two groups based on their serum
gliadin levels; patients who had been tested by an effi-
cient challenge with increased serum gliadin level
(Group III) and patients who had not been tested effi-
ciently without serum gliadin-increase (Group II).
The false-negative challenge performed in Group II
was confirmed by the retesting or wheat-elimination
diet and the result showed that 9 out of 10 Group II
patients were definiteprobable WDEIA, whereas the
Kohno K et al.
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Table　3　Results of retests or wheat elimination diet of Group II
Patient No. Retests Wheat elimination diet Final diagnosis
18 Positive Symptom-free Defi nite WDEIA
19 Positive Symptom-free Defi nite WDEIA
20 Positive Symptom-free Defi nite WDEIA
21 Negative Recurrent allergic symptoms were observed during exercise after ingestion 
of wheat containing meal and exercise.
Probable WDEIA
22 ND Anaphylaxis was observed after accidental exposure of wheat and exercise. Probable WDEIA
23 ND Symptom-free Probable WDEIA
24 ND Symptom-free Probable WDEIA
25 ND Symptom-free Probable WDEIA
26 ND Symptom-free Probable WDEIA
27 ND Symptoms were induced in spite of wheat eliminations. Non-WDEIA
result of normal diet treatment showed that 7 out of 9
Group III patients were non-WDEIA. Thus, the detec-
tion of serum gliadin and classification of patients by
its level during the challenge testing is of importance
for interpreting the negative challenge test result.
The cutoff line between Group II and III were di-
vided according to their serum gliadin level as being
undetectable or detectable (15 pgmL of cutoff
value). Although the cutoff line might be debatable,
we consider that this is the limitation of our current
methodology.
Previously we observed that the absorption of
wheat gliadin from the intestine varies according to
the individual.16 This might be because of individual
differences in intestinal sensitivity to exercise or aspi-
rin. In the present study, we detected gliadins using
anti-gliadin antibodies that bound to several types of
gliadin such as αβ-gliadin, γ-gliadin, and ω-gliadin.
Tanaka et al. recently reported that ω-5 gliadin is ab-
sorbed from the gastrointestinal tract more effec-
tively than other wheat components in a mouse
model.17 The same observation was obtained using
an in vitro caco-2 cell line model.18 Thus, the specific
detection of ω-5 gliadin seemed to provide effective
details for the diagnosis of WDEIA. From a practical
application standpoint, further study is required to de-
cide the optimum time to measure the serum gliadin
and to improve the complicated measurement
method.
Retesting with a wheat product other than noodles,
was succeeded in three of four patients (patients 18-
20). Patients 18 and 20 induced urticaria following a
retest that used bread instead of noodles. The differ-
ence of challenge test between noodles and bread
may be due to amount of gluten contained in the
same weight of wheat flour. Usually, wheat flour for
making bread contains more gluten than that for
making noodles.14
A high serum gliadin level (137 pgmL) was de-
tected during an allergic reaction induced by acciden-
tal ingestion of wheat products in patient 22. Serum
gliadin was not detected during the negative-
challenge tests (Table 2), indicating that this patient
was challenged with an insufficient amount of wheat
product or needed secondary factors. The lack of al-
lergen absorption in the gastrointestinal tract may ex-
plain the failure of challenge tests.
In this study, the diagnosis of WDEIA was made in
27 patients, including seven with probable WDEIA.
Of these 27 patients, 19 patients were challenged with
wheat plus exercise, and eight had a positive test (Ta-
ble 2). This shows a positive-induction rate of 42.1%
for the wheat plus exercise test. The induction rate of
the aspirin plus wheat test was the same as that for
the wheat plus exercise test (819; 42.1%). However,
of the eight patients challenged with aspirin plus
wheat plus exercise, six had a positive test (75.0%
positive induction rate), indicating an additive effect
of aspirin plus exercise. Exercise is known to in-
crease intestinal permeability.19 Aspirin also in-
creases gastrointestinal permeability20 and increases
serum gliadin levels in a dose-dependent fashion
when taken in combination with wheat.16 The com-
bined effects of NSAIDs plus exercise promote
greater gastrointestinal permeability to high-
molecular-weight substances.21,22 The mechanism of
NSAID-enhanced gastrointestinal permeability is
thought to involve decreased prostaglandin synthesis
mediated via the inhibition of cyclooxygenase. This is
supported by studies showing that co-administration
of prostaglandin E1 suppresses both allergic symp-
toms and serum gliadin levels during challenge tests
involving aspirin and wheat.23,24
Recently, two cases of WDEIA were reportedly in-
duced by aspirin, but not exercise.25 In our challenge
tests, patients 7 and 8 did not show symptoms, de-
spite their serum gliadin concentrations increased af-
ter ingesting wheat alone or in combination with ex-
ercise. However, symptoms were induced when chal-
lenged with aspirin plus wheat, with similar levels of
gliadin. These results suggest that co-administration
with aspirin may mediate mast cell activation in addi-
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Allergology International Vol 62, No2, 2013 www.jsaweb.jp 237
tion to increasing gastrointestinal tract permeability.
As we reported previously, HMW-glutenin showed
additional diagnostic effectiveness when combined
with ω-5 gliadin, because patients who have specific
IgE to HMW-glutenin do not have specific IgE to ω-5
gliadin. From the 36 patients in the study, 2427
(88.8%) of those with WDEIA, and 18 (12.5%) of
those with non-WDEIA, were positive against ω-5
gliadin- andor HMW-glutenin-specific IgE tests, re-
spectively. The limitation of the ω-5 gliadin-specific
IgE test has been demonstrated by another group.13
In fact, three patients (patients 7, 13 and 17) with defi-
nite WDEIA in the present study did not have IgE
against ω-5 gliadinHMW-glutenin. Patient 33 had
specific IgE against ω-5 gliadin (0.36 kUAL); how-
ever, he was diagnosed as non-WDEIA. We have re-
cently shown that the specific IgE test to ω-5 gliadin
can produce false positive results in 1.4% of Japanese
adults, and that could be the case with patient 33.26
In conclusion, serum gliadin monitoring during
challenge testing for WDEIA is helpful to extract the
patients with false negative results. However further
study is needed for the practical application of this
method.
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